Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme

Enzymes that act on multiple substrates are common in biology but pose unique challenges as therapeutic targets. The metalloprotease insulin-degrading enzyme (IDE) modulates blood glucose levels by cleaving insulin, a hormone that promotes glucose clearance. However, IDE also degrades glucagon, a ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Maianti, Juan Pablo, Tan, Grace A., Vetere, Amedeo, Welsh, Amie J., Wagner, Bridget K., Seeliger, Markus A., Liu, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551522/
https://www.ncbi.nlm.nih.gov/pubmed/31086331
http://dx.doi.org/10.1038/s41589-019-0271-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551522/
https://www.ncbi.nlm.nih.gov/pubmed/31086331
http://dx.doi.org/10.1038/s41589-019-0271-0

Ejemplares similares